The Centers for Disease Control and Prevention (CDC) recently updated the shortages & delays Web page to reflect Merck’s announcement that COMVAX® will no longer be produced as well as Sanofi’s removal of restrictions on supplies of Pentacel® and Daptacel®.
Are you aware of the CDC’s dedicated Web area for information related to teens and preteens? If not, check it out today. The site offers a variety of resources including print materials, podcasts, videos and radio PSAs. In addition, the CDC recently updated the site to reflect the latest NIS-Teen survey data.
The Global Advisory Committee on Vaccine Safety of the World Health Organization (WHO) recently met in Geneva and discussed four issues related to vaccine safety:
To read more about any of these issues, consult the Weekly Epidemiological Record published July 18, 2014.
The July 2014 issues of the Immunization Action Coalition (IAC) newsletters, Needle Tips and Vaccinate Adults, are now available online. Needle Tips is designed for healthcare professionals who administer vaccines, and Vaccinate Adults is a shortened version containing articles relevant to providers who only administer vaccines to adults.
Highlights of the July issue include:
Do you get the quarterly newsletter, Immunization Initiatives, produced by the AAP? If not, you may want to sign up or check out archived issues.
The July 2014 issue includes articles about timely immunization, information about the CDC’s “Think Measles” initiative and reminder/recall systems.
If you live in California, you now have another tool related to immunizations, and if you don’t, you will want it in your state too! Shots for School has a new tool that allows users to look up a specific school or schools in a particular zip code to see the percent of children in the school who are fully immunized.
Users can search childcare, kindergarten or 7th grade coverage rates. Percent coverage is shown on a map and color coded in groups of less than 80 percent, 80-94 percent, 95-100 percent or did not report.
The Centers for Disease Control and Prevention (CDC) recently updated several travel guidelines. Enhanced precautions (alert level 2) are recommended for travelers going to Syria, Equatorial Guinea, Iraq, Ethiopia, Cameroon and Somalia related to polio, and for those going to Liberia, Guinea and Sierra Leone related to Ebola virus. Schistosomiasis concern is elevated for travelers to Corsica in France, and travel guidelines were also posted in June for those planning to attend the Hajj and Umrah events.
Find out more»
The National Foundation for Infectious Diseases (NFID) is offering continuing education credits for review of a series about pertussis. The journal articles resulted from presentations at a working group meeting about pertussis that occurred in March 2013, and include information related to the changing epidemiology of the disease, clinical evaluation of existing vaccines and disease pathogenesis, as well as other topics.
NFID recently published a report, “Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses,” to share information related to the recent outbreaks at Princeton and the University of California, Santa Barbara (UCSB). In addition to providing situational summaries, the report describes challenges related to costs and lack of an approved vaccine as well as provides a series of recommendations related to these and other challenges identified during the experiences.
Editor’s Note: The serogroup B meningococcal vaccine used to control the Princeton and UCSB outbreaks, known as Bexero® and manufactured by Novartis, was submitted for licensure to the Food and Drug Administration in June 2014. Similarly, Pfizer’s serogroup B meningococcal vaccine has also been submitted for licensure.
The U.S. Centers for Disease Control and Prevention (CDC) recently announced the release of an updated version of the Vaccine Information Statement (VIS) for adenovirus. The date on the current version is June 11, 2014.
Finally, did you know that you can view VIS and supporting provider information on your mobile phone? Bookmark the mobile version of the VIS page at http://m.cdc.gov/VIS.
The Association of Immunization Managers (AIM) recently released a position statement related to personal belief exemptions (PBE) encouraging states and territories that do not allow PBE to maintain this position and those who do allow them to consider strengthening their position. The AIM position paper was in response to the increased risk of disease in communities that allow PBE.
The Immunization Action Coalition (IAC) has a handout titled “Decision to Not Vaccinate My Child” which includes excerpts from position statements from various national organizations. The form can be signed by the parent and kept on file to indicate the vaccines they refused. Read or print the sheet.
Medscape recently published an interview with Susan L. Hyman, MD, chair of the American Academy of Pediatrics (AAP) Autism subcommittee and a professor of pediatrics at the University of Rochester, discussing “The Reasons behind the Rise in Autism.” Read the interview.
If you do not have a free Medscape account, you will need to register before being able to access the article.
Parents of Kids with Infectious Diseases (PKIDS) recently launched a new campaign aimed at teens and young adults. Called “Your Choice!” The campaign reminds teens to “take control of your health.”
Materials on the site can be branded by your organization and submitted to local news organizations. FAQ sheets are also available for both teens and parents.
The Immunization Action Coalition (IAC) now has available for order useful laminated versions of the 2014 immunization schedules. The full-color schedules include a recommendations table, footnotes, contraindications and precautions. Two versions are available:
Costs vary by quantity ordered. Four or fewer copies are $7.50 each with prices decreasing incrementally to $3.50 per schedule for quantities of 500 to 999. Larger quantities are also available by contacting IAC.
Following the recent release of the Cochrane report about the benefits of antiviral drugs in treating influenza, the Centers for Disease Control and Prevention (CDC) re-emphasized their recommendations related to the use of antivirals for treating influenza. Specifically,
The Centers for Disease Control and Prevention (CDC) announced the introduction of a new Twitter account, @CDCizlearn. They plan to post information about immunization-related education, training and practice resources for healthcare providers and others interested in administration and delivery of vaccines. Questions about the Twitter account can be emailed to email@example.com.
The CDC has also announced removal of the multi-vaccine VIS (11/16/12), so that it can be updated. In the interim, rather than using that sheet, provide parents with the individual VISs. This information is posted on the CDC’s VIS announcements page.
The Immunization Partnership in Texas recently launched a new website, immunizeUSA.org. In addition to education and advocacy sections, the site includes a wonderful Tedx Talk video by Anna Dragsbaek, President and CEO of The Immunization Partnership. The Tedx Talk video, titled “The Scream That Should Be Heard Around the World,” is also available on YouTube.
The Centers for Disease Control and Prevention (CDC) recently made updates to the following Vaccine Information Statements (VIS):
Be sure you are using the most up-to-date VIS by checking the CDC’s summary page.
The CDC recently updated two modules in the “You Call the Shots” training course:
The “You Call the Shots” modules are free, Web-based training modules intended for nurses, medical assistants, pharmacists and other health professionals who administer immunizations. The modules are also useful for students in fields of study that will eventually administer vaccines. Continuing education credits are also available.
Cervivor is a new series launched by Tamika & Friends, a group of cervical cancer survivors. In this online series Tamika interviews other cervical cancer survivors as they share their stories of hope and survival. The group is having a three-day survivor retreat during January 2014.
Merck voluntarily recalled one lot of Gardasil® because a small number of vials might have been contaminated with glass introduced by breakage during the production process:
For more information, consult the CDC’s related media statement.
We welcome your input. Please contact us with story ideas, questions or other comments: